🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of PF 0449...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-12
Trial ID
NCT00566397
Treatments Being Tested
This is an open label study to determine the safety and preliminary evidenc...
Status
Unknown
Location
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Start Date
2023-06-01
Trial ID
NCT05766748
Treatments Being Tested
Current research indicates that TTP488 may be a viable agent for the treatm...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-02
Trial ID
NCT00287183
Treatments Being Tested
This is a study to evaluate the efficacy and safety of azeliragon in patien...
Status
Terminated
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02080364
Treatments Being Tested
This is an open-label extension study in patients with mild Alzheimer's dis...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02916056
Treatments Being Tested
To determine the safety and efficacy of using the drug azeliragon combined ...
Status
Suspended
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2023-11-17
Trial ID
NCT05789589
Treatments Being Tested
This is a study to evaluate the efficacy and safety of azeliragon in patien...
Status
Terminated
Location
Tucson Neuroscience Research
Start Date
2019-06-27
Trial ID
NCT03980730
Treatments Being Tested
This is a pilot study to evaluate the effects of azeliragon to decrease car...
Status
Recruiting
Location
Georgetown Lombardi Comprehensive Cancer Center
Start Date
2023-06-06
Trial ID
NCT05256745
Treatments Being Tested